Very recently, it was identified that NORE1A activates the cyclin-dependent kinase inhibitor p21WAF1 via promoting p53 nuclear localization, and loss of NORE1A expression correlates with loss of p21WAF1 in human hepatocellular carcinoma [21]. The gene discussed is CDKN3; the disease is hepatocellular carcinoma.